Use of antidepressants in children and risk of suicide: a review

Published

2007-12-01

How to Cite

Bel Aguado, M. J., Barrera Francés, A., & Gracia García, P. (2007). Use of antidepressants in children and risk of suicide: a review. Revista De Psiquiatría Infanto-Juvenil, 24(2, 3 y 4), 187–192. Retrieved from https://aepnya.eu/index.php/revistaaepnya/article/view/100

Issue

Section

Review article

Authors

  • M J Bel Aguado Hospital Clínico Universitario Lozano Blesa
  • A Barrera Francés Hospital Clínico Universitario Lozano Blesa
  • P Gracia García Hospital Clínico Universitario Lozano Blesa

Keywords:

Antidepressants, suicide, children

Abstract

Introduction: Depressive disorders during youth occur frequently (10%) and are associated with significant comorbidity. ISRS are an effective treatment that
was prescribed widely across 1990´s. The finding of a relation between the use of antidepressants and an increase of suicidal risk in young people has generated a great controversy in the last years. Objective: To evaluate the risk of the antidepressant use in childhood in relation to the suicidal ideation. Method: We review the current state of research into antidepressant therapy in children and adolescents. Data from randomised controlled trials published in medical
journals in the last five years were reviewed; we discuss methodologic issues and clinical implications. Results: We have found ten trials that treated about antidepressants and suicidal risk. Four of them suggest that antidepressants protect of suicide, whereas four of them indicated that the risk of suicidal behaviour is increased with antidepressant use. Two studies don´t show significant results. Conclusions: It´s necessary to make specific studies on this subject because the present studies don´t show conclusive results. Nevertheless, depressive disorders
must be treated because their wide frecuency in childhood and their serious comorbidity.

Downloads

Download data is not yet available.

Author Biographies

M J Bel Aguado, Hospital Clínico Universitario Lozano Blesa

Residente de psiquiatría

A Barrera Francés, Hospital Clínico Universitario Lozano Blesa

Residente de psiquiatría

P Gracia García, Hospital Clínico Universitario Lozano Blesa

Residente de psiquiatría

References

1. Baldessarini RJ, Pompili M, Tondo L. Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry. 2006; 63 (3): 246-8.

2. Brent DA. Antidepressants and pediatric depression--the risk of doing nothing. N Engl J Med. 2004; 351 (16): 1598-601.

3. Bridge JA, Barbe RP, Birmaher B, Kolko DJ, Brent DA. Emergent suicidality in a clinical psychotherapy trial for adolescent depression. Am J Psychiatry. 2005; 162 (11):2173-5.

4. Cheung AH, Emslie GJ, Mayes TL. The use of antidepressants to treat depression in children and adolescents. CMAJ 2006; 174 (2): 193-200.

5. Citrome L, Goldberg J. Commentary: bipolar disorder is a potentially fatal disease. Postgrad Med. 2005; (2):9-11.

6. Diller L. Antidepressants and children's depression. Am J Psychiatry. 2005; 162 (6):1226-7.

7. Foncke EM, Schuurman PR, Speelman JD. Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology 2006; 66(1):142-3.

8. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry. 2005; 62(2):165-72.

9. Greenhouse JB, Kelleher KJ. Thinking outside the (black) box: antidepressants, suicidality, and research synthesis. Pediatrics 2005; 116(1): 231-3.

10. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006; 63(3):332-9.

11. Lenzer J. FDA panel urges "black box" warning for antidepressants. BMJ 2004; 329(7468):702.

12. Leslie LK, Newman TB, Chesney PJ, Perrin JM. The Food and Drug Administration's deliberations on antidepressant use in pediatric patients. Pediatrics 2005;116(1):195-204.

13. Martinez C, Rietbrock S,Wise L et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005; 330(7488):389.

14. Murray ML, Wong IC, Thompson M. Do selective serotonin reuptake inhibitors cause suicide? Antidepressant prescribing to children and adolescents by GPs has fallen since CSM advice. BMJ 2005; 330(7500):1151.

15. Newman TB. A black-box warning for antidepressants in children? N Engl J Med. 2004;351(16):1595-8.

16. Ruchkin V, Martin A. SSRIs and the developing brain. Lancet 2005; 365(9458):451-3.

17. Ryan ND. Treatment of depression in children and adolescents. Lancet 2005;366(9489):933-40.

18. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006; 163(1):41-7.

19. Wegner LM. Pediatricians and antidepressant medications: black box or
black hole? Pediatrics 2005; 116(1):233-5.

20. Weiss JJ, Gorman JM. Antidepressant adherence and suicide risk in depressed youth. Am J Psychiatry. 2005; 162(9):1756-7.

21. Winters NC. Are antidepressants safe for adolescents? Postgrad Med. 2005; 118(3):33-4.